Jiaxuan Xia

1.4k total citations · 1 hit paper
29 papers, 1.0k citations indexed

About

Jiaxuan Xia is a scholar working on Molecular Biology, Immunology and Biomaterials. According to data from OpenAlex, Jiaxuan Xia has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Biomaterials. Recurrent topics in Jiaxuan Xia's work include Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Ginseng Biological Effects and Applications (5 papers). Jiaxuan Xia is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Ginseng Biological Effects and Applications (5 papers). Jiaxuan Xia collaborates with scholars based in China, South Korea and Japan. Jiaxuan Xia's co-authors include Ying Zhu, Anni Wang, Jianxin Wang, Shiyi Li, Chao Hong, Jianming Liang, Jianxin Wang, Jianxin Wang, Shuya Zhang and Hongwei Ren and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Global Change Biology.

In The Last Decade

Jiaxuan Xia

27 papers receiving 1.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-glioma effect of ginseng-derived exosomes-like nanoparticles by active blood–brain-barrier penetration and tumor microenvironment modulation

2023 149 citations Jisu Kim, Ying Zhu et al. Journal of Nanobiotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiaxuan Xia China	15	620	217	209	178	154	29	1.0k
Behrad Darvishi Iran	21	490 0.8×	223 1.0×	171 0.8×	138 0.8×	77 0.5×	41	1.2k
Jingjin He China	14	493 0.8×	78 0.4×	136 0.7×	82 0.5×	63 0.4×	20	895
Phil‐Sun Oh South Korea	20	314 0.5×	77 0.4×	136 0.7×	94 0.5×	92 0.6×	62	952
Meifang Liu China	18	370 0.6×	159 0.7×	83 0.4×	176 1.0×	43 0.3×	49	1.0k
Shyr‐Yi Lin Taiwan	20	597 1.0×	71 0.3×	58 0.3×	140 0.8×	88 0.6×	41	1.1k
Hassan Dariushnejad Iran	17	453 0.7×	123 0.6×	72 0.3×	135 0.8×	36 0.2×	47	908
Nataraju Angaswamy India	22	493 0.8×	108 0.5×	65 0.3×	159 0.9×	107 0.7×	41	1.4k
Marta Woźniak Poland	19	305 0.5×	51 0.2×	182 0.9×	97 0.5×	64 0.4×	66	864
Caisheng Wu China	20	388 0.6×	182 0.8×	169 0.8×	31 0.2×	69 0.4×	54	987
Matthew Brentnall United States	5	679 1.1×	61 0.3×	78 0.4×	127 0.7×	56 0.4×	7	1.2k

Countries citing papers authored by Jiaxuan Xia

Since Specialization

Citations

This map shows the geographic impact of Jiaxuan Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaxuan Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaxuan Xia more than expected).

Fields of papers citing papers by Jiaxuan Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaxuan Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaxuan Xia. The network helps show where Jiaxuan Xia may publish in the future.

Co-authorship network of co-authors of Jiaxuan Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Jiaxuan Xia. A scholar is included among the top collaborators of Jiaxuan Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiaxuan Xia. Jiaxuan Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xia, Jiaxuan, et al.. (2025). Blood Cell Ratio Combinations for Diagnosing Periprosthetic Joint Infections: A Preliminary Study. Infection and Drug Resistance. Volume 18. 635–645. 2 indexed citations

Xia, Jiaxuan, Jixian Zhang, Meichen Dong, et al.. (2025). Geometric-aware deep learning enables discovery of bifunctional ligand-based liposomes for tumor targeting therapy. Nano Today. 61. 102668–102668. 9 indexed citations

Xia, Jiaxuan, Yibao Jin, Yanjun Hong, et al.. (2025). Effects of gut microbiota dysbiosis on the metabolism and pharmacokinetics of losartan in rats: from endogenous to ceftriaxone-induced dysbiosis. Frontiers in Microbiology. 16. 1693247–1693247.

Mo, Ying‐Qian, Wenxin Zhou, Meifang Li, et al.. (2025). Sorafenib induces intestinal toxicity by disturbing gut microbiota and activating the LPS/TLR4/NF-κB signaling pathway in mice. Toxicology. 517. 154220–154220. 3 indexed citations

Leng, Yun, Qian Zhang, Jiaxuan Xia, et al.. (2024). Gallic acid attenuates murine ulcerative colitis by promoting group 3 innate lymphocytes, affecting gut microbiota, and bile acid metabolism. The Journal of Nutritional Biochemistry. 131. 109677–109677. 6 indexed citations

Leng, Yun, Qian Zhang, Ziqiong Liao, et al.. (2024). Gallic acid ameliorates colitis by modulating the Treg/Th17 balance via microbiota-derived secondary bile acids. Food Science and Human Wellness. 14(10). 9250235–9250235.

Hong, Chao, Anni Wang, Jiaxuan Xia, et al.. (2024). Ginsenoside Rh2-Based Multifunctional Liposomes for Advanced Breast Cancer Therapy. International Journal of Nanomedicine. Volume 19. 2879–2888. 10 indexed citations

Xia, Jiaxuan, Xing Chen, Meichen Dong, et al.. (2024). Antigen self-presenting dendrosomes swallowing nanovaccines boost antigens and STING agonists codelivery for cancer immunotherapy. Biomaterials. 316. 122998–122998. 6 indexed citations

Wang, Anni, Shiyi Li, Ru Zhang, et al.. (2024). Senescence-associated secretory phenotype regulation by dual drug delivery biomimetic nanoplatform for enhanced tumor chemotherapy. SHILAP Revista de lepidopterología. 32(3). 200856–200856. 2 indexed citations

10.

Xu, Yansen, Zhaozhong Feng, Manzhu Bao, et al.. (2024). Warming Mitigates Ozone Damage to Wheat Photosynthesis in a FACE Experiment. Plant Cell & Environment. 48(3). 2312–2328. 5 indexed citations

11.

Zhang, Shuya, et al.. (2024). Establishing Salvia miltiorrhiza-Derived Exosome-like Nanoparticles and Elucidating Their Role in Angiogenesis. Molecules. 29(7). 1599–1599. 9 indexed citations

12.

Kim, Jisu, Ying Zhu, Sunhui Chen, et al.. (2023). Anti-glioma effect of ginseng-derived exosomes-like nanoparticles by active blood–brain-barrier penetration and tumor microenvironment modulation. Journal of Nanobiotechnology. 21(1). 253–253. 149 indexed citations breakdown →

13.

Zhang, Longlong, Yuefei Zhu, Xunbin Wei, et al.. (2022). Nanoplateletsomes restrain metastatic tumor formation through decoy and active targeting in a preclinical mouse model. Acta Pharmaceutica Sinica B. 12(8). 3427–3447. 24 indexed citations

14.

Chen, Chen, Jiaxuan Xia, Hongwei Ren, et al.. (2022). Effect of the structure of ginsenosides on the in vivo fate of their liposomes. Asian Journal of Pharmaceutical Sciences. 17(2). 219–229. 29 indexed citations

15.

Xia, Jiaxuan, Shaojie Ma, Xi Zhu, et al.. (2022). Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches. Science Advances. 8(6). eabj1262–eabj1262. 98 indexed citations

16.

Xia, Jiaxuan, Shuya Zhang, Ru Zhang, et al.. (2022). Targeting therapy and tumor microenvironment remodeling of triple-negative breast cancer by ginsenoside Rg3 based liposomes. Journal of Nanobiotechnology. 20(1). 414–414. 55 indexed citations

17.

Zhu, Ying, Anni Wang, Shuya Zhang, et al.. (2022). Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells. Journal of Advanced Research. 49. 159–173. 104 indexed citations

18.

Zhang, Meng, Hongwei Ren, Kun Li, et al.. (2021). Therapeutic effect of various ginsenosides on rheumatoid arthritis. BMC Complementary Medicine and Therapies. 21(1). 149–149. 22 indexed citations

19.

Hong, Chao, Dan Wang, Jianming Liang, et al.. (2019). Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer. Theranostics. 9(15). 4437–4449. 126 indexed citations

20.

Xia, Jiaxuan, et al.. (2019). Simultaneous determination of phenolic acids and flavonoids in Artemisiae Argyi Folium by HPLC-MS/MS and discovery of antioxidant ingredients based on relevance analysis. Journal of Pharmaceutical and Biomedical Analysis. 175. 112734–112734. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact